CVE-2022-45611

View on CVE.org

Published Aug 22, 2023 CVSS 3.1 · 9.8 Critical EPSS 1.2% KEV · Not listed

Description

An issue was discovered in Fresenius Kabi PharmaHelp 5.1.759.0 allows attackers to gain escalated privileges via via capture of user login information.

Analysis

No analysis available yet

Affected Products

Default status is the baseline for the product, each version can override it (e.g. patched versions marked unaffected).

Vendor Product Default status Versions

n/a

n/a

affected

Version	Status	Constraints
`n/a`	affected	—

Configuration 1 [-]

AND

cpe:2.3:o:fresenius-kabi:pharmahelp_firmware:5.1.759.0:*:*:*:*:*:*:*

cpe:2.3:h:fresenius-kabi:pharmahelp:-:*:*:*:*:*:*:*

No data.

No data available yet.

Remediation

No remediation available yet

Tracking

Sign in to view the affected projects.

Advisories

No advisories available

Metrics

No CVSS v4.0

Attack Vector Network

Attack Complexity Low

Privileges Required None

Scope Unchanged

Confidentiality Impact High

Integrity Impact High

Availability Impact High

User Interaction None

No CVSS v3.0

No CVSS v2

This CVE is not in the KEV list.

Exploit prediction score: 1.2% (1.177% probability within 30 days)

Exploitation none

Automatable yes

Technical Impact total

References

Link	Providers
https://www.fresenius-kabi.com/de-at/produkte/pharmahelp-compounder
https://www.fresenius.com/sites/default/files/2023-11/Fresenius%20-%20CVE-2022-45611.pdf
https://www.fresenius.com/sites/default/files/2023-12/Fresenius%20-%20CVE-2022-45611.pdf

History

Nov 27, 2024 3:15 PM Scoring metrics updated View changes

Type	Values Removed	Values Added
Metrics		ssvc `{'options': {'Automatable': 'yes', 'Exploitation': 'none', 'Technical Impact': 'total'}, 'version': '2.0.3'}`

Subscriptions

Fresenius-kabi Pharmahelp Pharmahelp Firmware

Weaknesses

CWE-522
Insufficiently Protected Credentials

Sources

CVE record Updated: Nov 27, 2024, 2:25 PM

Status: PUBLISHED
Assigner: mitre
Published: Aug 22, 2023, 12:00 AM
Updated: Nov 27, 2024, 2:25 PM
Reserved: Nov 21, 2022, 12:00 AM

View source JSON

Vulnrichment Updated: Aug 3, 2024, 2:17 PM

Updated: Aug 3, 2024, 2:17 PM

NVD Updated: Jun 17, 2026, 5:10 AM

Status: Modified
Published: Aug 22, 2023, 7:16 PM
Modified: Jun 17, 2026, 5:10 AM

View source JSON

Red Hat No data

No data.

OpenCVE enrichment No data

No data.

{"affected": [{"affectedData": [{"product": "n/a", "vendor": "n/a", "versions": [{"status": "affected", "version": "n/a"}]}], "source": "cve@mitre.org"}], "configurations": [{"nodes": [{"cpeMatch": [{"criteria": "cpe:2.3:o:fresenius-kabi:pharmahelp_firmware:5.1.759.0:*:*:*:*:*:*:*", "matchCriteriaId": "D5E59598-8FC8-4D4D-833F-B21A7F2B55F8", "vulnerable": true}], "negate": false, "operator": "OR"}, {"cpeMatch": [{"criteria": "cpe:2.3:h:fresenius-kabi:pharmahelp:-:*:*:*:*:*:*:*", "matchCriteriaId": "D254891C-7278-4F2A-B422-AA874C3E16AC", "vulnerable": false}], "negate": false, "operator": "OR"}], "operator": "AND"}], "cveTags": [], "descriptions": [{"lang": "en", "value": "An issue was discovered in Fresenius Kabi PharmaHelp 5.1.759.0 allows attackers to gain escalated privileges via via capture of user login information."}], "id": "CVE-2022-45611", "lastModified": "2026-06-17T05:10:27.117", "metrics": {"cvssMetricV31": [{"cvssData": {"attackComplexity": "LOW", "attackVector": "NETWORK", "availabilityImpact": "HIGH", "baseScore": 9.8, "baseSeverity": "CRITICAL", "confidentialityImpact": "HIGH", "integrityImpact": "HIGH", "privilegesRequired": "NONE", "scope": "UNCHANGED", "userInteraction": "NONE", "vectorString": "CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H", "version": "3.1"}, "exploitabilityScore": 3.9, "impactScore": 5.9, "source": "nvd@nist.gov", "type": "Primary"}], "ssvcV203": [{"source": "134c704f-9b21-4f2e-91b3-4a467353bcc0", "ssvcData": {"id": "CVE-2022-45611", "options": [{"exploitation": "none"}, {"automatable": "yes"}, {"technicalImpact": "total"}], "role": "CISA Coordinator", "timestamp": "2024-11-27T14:24:35.463508Z", "version": "2.0.3"}}]}, "published": "2023-08-22T19:16:30.167", "references": [{"source": "cve@mitre.org", "tags": ["Product"], "url": "https://www.fresenius-kabi.com/de-at/produkte/pharmahelp-compounder"}, {"source": "cve@mitre.org", "url": "https://www.fresenius.com/sites/default/files/2023-11/Fresenius%20-%20CVE-2022-45611.pdf"}, {"source": "cve@mitre.org", "url": "https://www.fresenius.com/sites/default/files/2023-12/Fresenius%20-%20CVE-2022-45611.pdf"}, {"source": "af854a3a-2127-422b-91ae-364da2661108", "tags": ["Product"], "url": "https://www.fresenius-kabi.com/de-at/produkte/pharmahelp-compounder"}, {"source": "af854a3a-2127-422b-91ae-364da2661108", "url": "https://www.fresenius.com/sites/default/files/2023-11/Fresenius%20-%20CVE-2022-45611.pdf"}, {"source": "af854a3a-2127-422b-91ae-364da2661108", "url": "https://www.fresenius.com/sites/default/files/2023-12/Fresenius%20-%20CVE-2022-45611.pdf"}], "sourceIdentifier": "cve@mitre.org", "vulnStatus": "Modified", "weaknesses": [{"description": [{"lang": "en", "value": "CWE-522"}], "source": "nvd@nist.gov", "type": "Primary"}]}